PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

NASA investigating the life of Comet ISON

2013-12-03
(Press-News.org) Contact information: Susan Hendrix
Susan.m.hendrix@nasa.gov
301-286-7745
NASA/Goddard Space Flight Center
NASA investigating the life of Comet ISON

After several days of continued observations, scientists continue to work to determine and to understand the fate of Comet ISON: There's no doubt that the comet shrank in size considerably as it rounded the sun and there's no doubt that something made it out on the other side to shoot back into space. The question remains as to whether the bright spot seen moving away from the sun was simply debris, or whether a small nucleus of the original ball of ice was still there. Regardless, it is likely that it is now only dust.

Comet ISON, which began its journey from the Oort Cloud some 3 million years ago, made its closest approach to the sun on Nov. 28, 2013. The comet was visible in instruments on NASA's Solar Terrestrial Relations Observatory, or STEREO, and the joint European Space Agency/NASA Solar and Heliospheric Observatory, or SOHO, via images called coronagraphs. Coronagraphs block out the sun and a considerable distance around it, in order to better observe the dim structures in the sun's atmosphere, the corona. As such, there was a period of several hours when the comet was obscured in these images, blocked from view along with the sun. During this period of time, NASA's Solar Dynamics Observatory could not see the comet, leading many scientists to surmise that the comet had disintegrated completely. However, something did reappear in SOHO and STEREO coronagraphs some time later – though it was significantly less bright.

Whether that spot of light was merely a cloud of dust that once was a comet, or if it still had a nucleus – a small ball of its original, icy material – intact, is still unclear. It seems likely that as of Dec. 1, there was no nucleus left. By monitoring its changes in brightness over time, scientists can estimate whether there's a nucleus or not, but our best chance at knowing for sure will be if the Hubble Space Telescope makes observations later in December 2013.

Regardless of its fate, Comet ISON did not disappoint researchers. Over the last year, observatories around the world and in space gathered one of the largest sets of comet observations of all time, which should provide fodder for study for years to come. The number of space-based, ground-based, and amateur observations were unprecedented, with twelve NASA space-based assets observing over the past year.



INFORMATION:



Related Links:

For more information on Comet ISON: http://www.nasa.gov/ison

To download recent ISON imagery: http://svs.gsfc.nasa.gov/Gallery/CometISON.html



ELSE PRESS RELEASES FROM THIS DATE:

Genetic mutation may play key role in risk of lethal prostate cancer in overweight patients

2013-12-03
Genetic mutation may play key role in risk of lethal prostate cancer in overweight patients Boston, MA — Obesity is associated with a worse prostate cancer prognosis among men whose tumors contain a specific genetic mutation, suggest results from a new study ...

NASA's HS3 hurricane mission called it a wrap for 2013

2013-12-03
NASA's HS3 hurricane mission called it a wrap for 2013 NASA's Hurricane and Severe Storms Sentinel airborne mission known as HS3 wrapped up for the 2013 Atlantic Ocean hurricane season at the end of September, and had several highlights. HS3 will return ...

SU biologist develops method for monitoring shipping noise in dolphin habitat

2013-12-03
SU biologist develops method for monitoring shipping noise in dolphin habitat Nathan Merchant is exploring the link between man-made noise and marine mammal populations A biologist in Syracuse University's College of Arts and Sciences has developed a system of techniques for ...

Osteoporosis drugs compared for side effects, efficacy in Loyola study

2013-12-03
Osteoporosis drugs compared for side effects, efficacy in Loyola study A study comparing the efficacy and tolerability of two popular osteoporosis drugs, denosumab and zoledronic acid, found that denosumab had a significantly greater effect on increasing spine ...

Micromovements hold hidden information about severity of autism, researchers report

2013-12-03
Micromovements hold hidden information about severity of autism, researchers report INDIANAPOLIS -- Movements so minute they cannot be detected by the human eye are being analyzed by researchers to diagnose autism spectrum disorder and determine its severity in children and ...

Vitamin D decreases pain in women with type 2 diabetes and depression

2013-12-03
Vitamin D decreases pain in women with type 2 diabetes and depression Vitamin D decreases pain in women with type 2 diabetes and depression, according to a study conducted at Loyola University Chicago. These findings were presented at an Oct. 24, 2013 research ...

Airborne radar looking through thick ice during NASA polar campaigns

2013-12-03
Airborne radar looking through thick ice during NASA polar campaigns The bedrock hidden beneath the thick ice sheets covering Greenland and Antarctica has intrigued researchers for years. Scientists are interested in how the shape of this hidden terrain ...

New technique identifies pathogens in patient samples faster, in great detail

2013-12-03
New technique identifies pathogens in patient samples faster, in great detail A team of Danish investigators has shown how to identify pathogens faster, directly from clinical samples. The research, published online ahead of print in the Journal of Clinical ...

New research shows promise for possible HIV cure

2013-12-03
New research shows promise for possible HIV cure CHICAGO – Researchers have used radioimmunotherapy (RIT) to destroy remaining human immunodeficiency virus (HIV)-infected cells in the blood samples of patients treated with antiretroviral therapy, offering ...

Breast tomosynthesis increases cancer detection and reduces recall rates

2013-12-03
Breast tomosynthesis increases cancer detection and reduces recall rates CHICAGO – Researchers have found that digital breast tomosynthesis (DBT) led to reduced recall rates and an increase in cancer detection in a large breast cancer screening program. ...

LAST 30 PRESS RELEASES:

Black youth, especially Black girls, use mental health services less than their White peers

Canada must protect youth from sports betting advertising

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

[Press-News.org] NASA investigating the life of Comet ISON